Redirigiendo al acceso original de articulo en 18 segundos...
ARTÍCULO
TITULO

Precision Recruitment and Engagement of Individuals at Risk for Diabetes and Hypertension in Clinical Trials (PREDHICT): A Randomized Trial for an E-Persuasive Mobile Application to Inform Decision Making about Clinical Trials

Azizi Seixas    
Shannique Richards    
Jesse Q. Moore    
Chigozirim Izeogu    
Laronda A. Hollimon    
Peng Jin and Girardin Jean-Louis    

Resumen

The primary objective of this randomized trial was to test the effectiveness of the PREDHiCT digital application, which provides educational and supportive navigation to increase willingness to participate in a future clinical trial. The second objective was to test whether PREDHiCT increased clinical trial literacy or enhanced psychological facilitators of clinical trial participation, such as altruism. To test these two objectives, we conducted a 1-month remote decentralized trial with 100 participants who either have a personal or family history of cardiometabolic health conditions, such as hypertension, diabetes, and obesity. Results indicated significant changes in altruism (mean: -2.94 vs. 0.83; p-value = 0.011) and clinical trial literacy (mean: 0.55 vs. 2.59; p-value = 0.001) from baseline to 1-month follow-up between the control and intervention groups. Additionally, participants exposed to personalized clinical trial navigation had greater clinical trial literacy at the end of the study relative to the individuals in the control arm of the study. Our findings indicate that tailored education, navigation, and access to clinical trials?three unique features of our PREDHiCT app?increased altruism and clinical trial literacy but not willingness to participate in a trial.

 Artículos similares

       
 
Alana Smith, Gregory A. Vidal, Elizabeth Pritchard, Ryan Blue, Michelle Y. Martin, LaShanta J. Rice, Gwendolynn Brown and Athena Starlard-Davenport    
African American women are substantially underrepresented in breast cancer genetic research studies and clinical trials, yet they are more likely to die from breast cancer. Lack of trust in the medical community is a major barrier preventing the successf... ver más

 
Shandir Ramlagan, Karl Peltzer, Robert A. C. Ruiter, Nicole A. Barylski, Stephen M. Weiss and Sibusiso Sifunda    
The possibility for all babies to be born and remain HIV-negative for the first year of life is achievable in South Africa. HIV-positive mothers? adherence to their antiretroviral medication is one of the crucial factors to achieve this target. Cross-sec... ver más

 
Xiaofang Zhang, Xiaodong Zhang, Bojun Yuan, Lijun Ren, Tianbao Zhang and Guocai Lu    
Histone deacetylase inhibitors (HDACIs), such as vorinostat and panobinostat, have been shown to have active effects on many hematologic malignancies, including multiple myeloma and cutaneous T-cell lymphoma. Hydroxamate-based (Hb) HDACIs have very good ... ver más